Atticus Wealth Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Atticus Wealth Management's RGEN Position: Q4 2022 in Review
Atticus Wealth Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 3 shares.
Atticus Wealth Management first reported a position in RGEN in Q3 2021 and held it in 5 quarters. The position peaked at $96K in Q3 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.
- Atticus Wealth Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
- Atticus Wealth Management sold 3 Repligen shares in Q4 2022.
- Atticus Wealth Management first reported a position in Repligen in Q3 2021 and held it in 5 quarters.
- Atticus Wealth Management's Repligen position peaked at $96K in Q3 2021.
- 442 funds tracked by Wall St. Rank held Repligen as of Q4 2022.
Based on Atticus Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.